NCT01330082

Brief Summary

The aim of this randomized clinical trial is to clinically evaluate the effectiveness of the adjunctive use of photodynamic therapy (PDT) with an light-emitting diode (LED) light source in the treatment of chronic periodontitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Apr 2010

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 6, 2011

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

April 6, 2011

Status Verified

April 1, 2011

Enrollment Period

7 months

First QC Date

April 4, 2011

Last Update Submit

April 5, 2011

Conditions

Keywords

Photodynamic therapyLight-emitting diodetoluidine bluescaling and root planing

Outcome Measures

Primary Outcomes (1)

  • Probing pocket depth

    distance from gingival margin to base of the clinical pocket by William's periodontal probe

    Baseline, one month, three month

Secondary Outcomes (3)

  • Clinical attachment loss

    Baseline, one month, three month

  • Bleeding upon probing

    Baseline, one month, three month

  • plaque index

    Baseline,before PDT procedure, one month, three month

Study Arms (3)

Photodynamic therapy

EXPERIMENTAL

will be treated by PDT using Light-emitting diod(LED) (625-635nm,200mw/cm2 ,30 s for each site, fotoson CMS Dental ,Denmark) in the presence of toluidine blue O (TBO)

Other: Adjunctive Photodynamic Therapy

Light-emitting diode Irradiation

EXPERIMENTAL

will be treated only by using Light-emitting diode(LED) (625-635nm,200mw/cm2 ,30 s for each site, fotoson CMS Dental ,Denmark)

Other: Light-emitting diod Irradiation

applying photosensitizer

EXPERIMENTAL

will be treated only by toluidine blue O

Other: applying Photosensitizer

Interventions

using Light-emitting diod(LED) (625-635nm,200mw/cm2 ,30 s for each site, fotoson CMS Dental ,Denmark) in the presence of toluidine blue O (TBO)

Photodynamic therapy

625-635nm,200mw/cm2 ,30 s for each site, fotoson CMS Dental ,Denmark

Light-emitting diode Irradiation

toluidine blue O is applied at the bottom of each periodontal pocket

applying photosensitizer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinically diagnosis of advanced chronic periodontitis with more than 3 mm clinical attachment loss
  • presence of at least two teeth with probing depth of 4 to 6 mm without furcation involvement in each quadrant
  • at least 16 remaining teeth
  • no periodontal treatment in the past 12 months
  • no evidence of systemic disease related to periodontal problems
  • no use of antibiotics for the past 6 months
  • No smoking more than 10 cigarettes per day
  • no addiction to any kind of drugs
  • no pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tehran University of Medical Sciences

Tehran, Tehran Province, 141555583, Iran

Location

MeSH Terms

Conditions

Chronic Periodontitis

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Neda Moslemi, DDS,MS

    Tehran University of Medical Sciences

    STUDY CHAIR
  • Seyed Hossein Bassir, DDS

    Tehran University of Medical Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 4, 2011

First Posted

April 6, 2011

Study Start

April 1, 2010

Primary Completion

November 1, 2010

Study Completion

May 1, 2011

Last Updated

April 6, 2011

Record last verified: 2011-04

Locations